2020
DOI: 10.1021/acsmedchemlett.0c00119
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of a Potent Anticancer Agent PVHD303 with in Vivo Activity

Abstract: As a part of our continuous structure–activity relationship (SAR) studies on 1-(quinazolin-4-yl)-1-(4-methoxyphenyl)­ethan-1-ols, the synthesis of derivatives and their cytotoxicity against the human lung cancer cell line A549 were explored. This led to the discovery of 1-(2-(furan-3-yl)­quinazolin-4-yl)-1-(4-methoxyphenyl)­ethan-1-ol (PVHD303) with potent antiproliferative activity. PVHD303 disturbed microtubule formation at the centrosomes and inhibited the growth of tumors dose-dependently in the HCT116 hum… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 13 publications
(31 reference statements)
0
6
0
Order By: Relevance
“…PVHD121 and its more potent derivative, PVHD303, (Figure 2A) are quinazoline derivatives that compete for colchicine binding to tubulin and inhibit tubulin polymerization in vitro . 16,17 The cellular effects of these compounds, however, are thought to be distinct from colchicine, which has raised the possibility that there is an alternative cellular target. 17,18 Cells treated with relatively high concentrations of PVHD121 or PVHD303 have abnormal spindles and no microtubules, consistent with inhibition of tubulin polymerization.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…PVHD121 and its more potent derivative, PVHD303, (Figure 2A) are quinazoline derivatives that compete for colchicine binding to tubulin and inhibit tubulin polymerization in vitro . 16,17 The cellular effects of these compounds, however, are thought to be distinct from colchicine, which has raised the possibility that there is an alternative cellular target. 17,18 Cells treated with relatively high concentrations of PVHD121 or PVHD303 have abnormal spindles and no microtubules, consistent with inhibition of tubulin polymerization.…”
Section: Resultsmentioning
confidence: 99%
“…However, at concentrations close to the anti-proliferative IC 50 of the respective compounds, cells exhibit a more specific defect in centrosome-specific micronucleation. 17,18 These differences could be explained by either a different binding mode or an alternative target, and the identification of compound resistant mutations using iHCT116 might help differentiate between these two possibilities.…”
Section: Target Deconvolution For Pvhd303 a Tubulin Binder With A Put...mentioning
confidence: 99%
“…Indeed, pyridine and furan derivatives have been recently reported to possess pharmacological potential as fungicidal, 6 , 7 anti-inflammatory, 8 , 9 antiviral, 10 , 11 antibacterial, 12 , 13 and even anticancer agents. 14 , 15 …”
Section: Introductionmentioning
confidence: 99%
“…In recent years, the fused heterocyclic compounds containing bridgehead nitrogen- or oxygen-donor atoms have attracted great interest due to their biological activities and chemical medicinal properties. Indeed, pyridine and furan derivatives have been recently reported to possess pharmacological potential as fungicidal, , anti-inflammatory, , antiviral, , antibacterial, , and even anticancer agents. , …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation